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he mitochondrial electron transport chain is essential to Plasmodium and is the target of the antimalar-
al drug atovaquone. The mitochondrial genomes of Plasmodium sp. are the most reduced known, and
he majority of mitochondrial proteins are encoded in the nucleus and imported into the mitochon-
rion post-translationally. Many organisms have signalling pathways between the mitochondria and
he nucleus to regulate the expression of nuclear-encoded mitochondrially-targeted proteins, for exam-
le in response to mitochondrial dysfunction. We have studied the transcript proﬁles of synchronous
lasmodium falciparum treated with an LD50 concentration of the complex III inhibitor antimycin A, to
nvestigate whether such pathways exist in the parasite. There was a broad perturbation of gene expres-
ion. The differentially expressed genes were enriched for transcripts encoding proteins involved in
nvasion, stress response, nucleotide biosynthesis and respiration. Some effects were attributable to
delay in the gene expression phase of drug-treated parasites. However, our data indicated regulation
f mitochondrial stress response genes and genes involved in pyrimidine biosynthesis, implying the
xistence of a signalling pathway from the mitochondrion to the nucleus.
2012 Elsevier GmbH.
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ntroduction
lasmodium sp. mitochondria are the site of a
umber of biochemical reactions including an
nusual, bifurcated tricarboxylic acid (TCA) cycle
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(Olszewski et al. 2010), iron-sulphur cluster bio-
genesis, ubiquinone synthesis and stages of haem
synthesis (van Dooren et al. 2006). Mitochondria
are typically the site of ATP synthesis via the
mitochondrial electron transport chain (mtETC);
sequential redox reactions drive the translocation of
protons across the inner mitochondrial membrane
(IMM) generating membrane potential across
the IMM which is harnessed for the synthesis of
ATP via ATP synthase. However, the Plasmodium
mtETC is not believed to contribute to ATP produc-
tion during blood stage malaria infection (Fry et al.
1990). A functional mtETC is nonetheless essential
2012 Elsevier GmbH.
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and the Qo site of the cytochrome bc1 complex is
the target of the antimalarial drug atovaquone (Fry
and Pudney 1992). Treatment of parasites with
compounds such as atovaquone results in loss of
membrane potential (Srivastava et al. 1997) and
killing of the parasite. The mtETC of Plasmodium
sp. has a number of unusual features including
a single subunit, non-proton translocating NADH
dehydrogenase and a cytochrome c oxidase sub-
unit 2 that is split into two proteins (Gardner et al.
2002). The Plasmodium mtETC has ﬁve sources
of electrons that can reduce ubiquinone; the
aforementioned NADH dehydrogenase, succinate
dehydrogenase, FAD-linked glycerol-3-phosphate
dehydrogenase, malate:quinone oxidoreductase
(which replaces malate dehydrogenase in the TCA
cycle (van Dooren et al. 2006)) and dihydroorotate
dehydrogenase (DHOD). DHOD is central to
pyrimidine biosynthesis and, like most eukaryotic
DHODs, donates its electrons to coenzyme Q.
These electrons are then fed into the mtETC.
Transfection of P. falciparum D10 parasites with a
fumarate-dependent DHOD from yeast gave rise
to atovaquone-resistant parasites (Painter et al.
2007), presumably due to the loss of dependence
of pyrimidine biosynthesis on releasing electrons
into the cytochrome bc1 complex via coenzyme Q.
Furthermore, these parasites were also resistant to
other bc1 complex inhibitors; the IC50 of the Qi site
inhibitor antimycin A rose from 129.4 nM to over
33000 nM, indicating the speciﬁcity of this drug for
the bc1 complex in P. falciparum. Further evidence
for this speciﬁcity comes from the observation that
parasites selected for resistance against one bc1
complex inhibitor became resistant to a number
of others (including antimycin A) while remaining
sensitive to inhibitors of other metabolic pathways
(Smilkstein et al. 2008).
The majority of Plasmodium mitochondrial pro-
teins are encoded in the nucleus and imported into
themitochondrion post-translationally and thePlas-
modium mitochondrial genome is the most reduced
known (Barbrook et al. 2010). In many organ-
isms, the expression of a number of these nuclear
genes is subject to transcriptional regulation; in
mammalian systems, subunits of all mtETC compo-
nents (including ATP synthase) are subject to such
control, for example throughout the cell cycle, or
in response to temperature change or mitochon-
drial dysfunction (Scarpulla 2002). Furthermore,
genes for import proteins and chaperones such
as Tom20 and mtCpn10 are also subject to tran-
scriptional regulation (Scarpulla 2002). mtETC
components can be regulated by other means such
as phosphorylation and allosteric mechanisms.
Regulation of cytochrome c oxidase (complex IV)
and cytochrome c has received attention. Complex
IV is regulated by membrane potential, phospho-
rylation and allosterically by ATP, and cytochrome
c is inhibited by phosphorylation (Hüttemann et al.
2007).
Cellular status andmitochondrial dysfunction sig-
nal changes in nuclear gene expression allowing
the maintenance of essential metabolic pathways
(Epstein et al. 2001; Hüttemann et al. 2007;
Scarpulla 2002). Signalling from mitochondria to
the nucleus has been well studied in yeast. One
key pathway depends on a heterodimeric tran-
scription factor consisting of Rtg1p and Rtg3p,
along with its positive regulator, Rtg2p. As well as
regulating basal expression, during times of mito-
chondrial perturbation (for example, in cells lacking
mitochondrial DNA) these proteins are required
for the enhanced expression of genes involved in
maintaining glutamate production (Liu and Butow
2006). Yeast cells treated with the mtETC inhibitor
antimycin A exhibit altered expression of genes
linked to the maintenance of glutamate synthe-
sis. Additionally, some elements of the antimycin
A response in yeast are independent of these
proteins; in particular, numerous transporters and
permeases exhibit upregulation independent of the
Rtg proteins (Epstein et al. 2001).
It is not known whether regulation of mtETC
components occurs at either the protein- or
transcript-level in Plasmodium. Our own searches
of the P. falciparum genome failed to iden-
tify orthologues of components of the typical
RTG-dependent mitochondria-nucleus signalling
pathway. However, given the essential nature of the
Plasmodium mtETC, we postulated that despite the
organism’s ‘hard wired’ patterns of gene expression
(Ganesan et al. 2008), transcriptional regulation
may occur to maintain mtETC function in response
to mitochondrial dysfunction. As antimycin A was
sufﬁcient to induce a retrograde signalling response
in yeast (Epstein et al. 2001), we studied global
gene expression responses of P. falciparum to
antimycin A. While sensitivity of P. falciparum to
antimycin A is well documented, there is much dis-
crepancy over the lethal concentrations of the drug
in different strains. Consequently, we initially estab-
lished the LD50 concentration of antimycin A across
one full lifecycle inP. falciparum 3D7parasites. Sub-
sequently, we assessed global changes in gene
expression in response to the drug using microar-
rays. A large number of genes exhibited differential
expression upon drug treatment, including genes
involved in multiple metabolic pathways. In abso-
lute terms, we detected little induction of stress
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response genes. However, there appeared to be an
enrichment of transcripts for stress response genes
relative to their representation within the parasite
genome. We also noted changes in expression of
genes encoding cytoskeletal and invasion related
proteins, which could be attributed to a delay
in the gene expression proﬁles of the parasites.
An enrichment of differentially expressed tran-
scripts for proteins involved in respiration and the
upregulation of transcripts encoding mitochondrial
chaperones was in keeping with the effects of
mtETC inhibition, such as production of reactive
oxygen species. Given the presumed inhibitory
effects of antimycin A on dihydroorotate dehydroge-
nase (due to prevention of regeneration of oxidised
ubiquinone by the bc1 complex) it was also inter-
esting to observe enrichment among upregulated
genes of a number of transcripts for enzymes
involved in nucleotide biosynthesis and in partic-
ular, pyrimidine biosynthesis. These data support
the vital nature of this pathway to parasite survival.
Furthermore, these data indicate that communi-
cation from the mitochondrion to the nucleus can
occur in P. falciparum in response to mitochondrial
dysfunction. While the mechanisms underlying this
pathway are unclear, evidence for interorganellar
communication inPlasmodium raises the prospects
of novel drug targets for future investigation.
Results
Dose-dependent Effects of Antimycin A
Treatment on the Growth of P. falciparum
in Vitro
Published LD50 values of antimycin A in P. falci-
parum range from13nM in theD6 strain (Smilkstein
et al. 2008) to 5.5M in the FCC strain (Geary
et al. 1989). We sought to ascertain the LD50 con-
centration of antimycin A in 3D7 parasites. We
were interested in the drug concentration sufﬁcient
to prevent progression of 50% of 3D7 parasites
through one full cell cycle, rather than assessing
inhibition of metabolism (such as DNA synthesis,
which could be directly affected by the inﬂuence of
the drug on pyrimidine biosynthesis). To determine
LD50 under the conditions used here, synchronous,
ring-stage parasites were treated for 48 hours with
a range of concentrations of antimycin A. Parasite
survival was deﬁned as the proportion of parasites
to complete one lifecycle successfully relative to
untreated controls (Fig. 1). Only ring stage par-
asites were counted. We have used this simple
technique to determine lethality over one lifecycle
Figure 1. Infection of RBCs with ring stage parasites
relative to controls after 48 hours incubation in the
presence of varying concentrations of antimycin A.
Error bars represent the combined standard deviation
of proportions of parasitaemia in treated and control
samples.
for other drugs (Tarr et al. 2011) and found our
results to be consistent with those of other laborato-
ries using both radiolabelled hypoxanthine uptake
and DNA-binding dye assays (data not shown).
The dose response curve in Figure 1 suggested
an LD50 concentration of 600 nM antimycin A. This
LD50 concentration is unlikely to lead to off-target
effects, since parasites with resistance to a range
of complex III inhibitors had an increased LD50
for antimycin A in excess of 2500 nM (Smilkstein
et al. 2008). At 600 nM antimycin A, there was lit-
tle observable phenotypic effect on growth over
the ﬁrst 24 hours of the parasite lifecycle (not
shown). Consequently, a 24 hour, 600 nMantimycin
A treatment was chosen for global gene expression
analysis.
Global Responses of P. falciparum to
Antimycin A
We used microarrays to characterise the global
gene expression response of P. falciparum to
600 nM antimycin A over 24 hours. The data
obtained were processed using GCRMA and anal-
ysed for differential gene expression using LIMMA.
Based on a cut-off threshold of Bonferroni-Holm
adjusted p<0.001, 475 genes were classiﬁed as
being differentially expressed between antimycin
A-treated and untreated cultures. qRT-PCR
analysis of twelve transcripts showed a strong
correlation with the microarray data (Fig. 2;
Spearman’s =0.881, p = 0.0035).
Two hundred and ﬁfteen genes were found to
be upregulated and 260 genes were found to be
downregulated. The fold changes in expression
758 S.J. Tarr et al.
Figure 2. Correlation of microarray and qRT-PCR fold
change values.
were small; the median increase in expression
was 2.485 fold and the median decrease in
expression was 0.200 fold. 107 genes encoded
proteins of unknown function. The remaining
genes were placed into functional categories.
Upregulated genes are shown in Supplementary
Table 2 and downregulated genes are shown in
Supplementary Table 3. The categorisations of dif-
ferentially expressed up- and downregulated genes
(excluding those of unknown function) are shown in
Figure 3.
Gene Ontology Enrichment Analysis
We sought to assess whether particular func-
tional groups of genes were enriched within the
dataset of differentially expressed genes relative
to their representation within the parasite genome.
We used the online gene ontology enrichment
analysis tool of DAVID (Database for Annotation,
Figure 3. Functional categorisation of up- and downregulated genes differentially expressed upon treatment
of P. falciparum with antimycin A (excluding proteins of unknown function), p < 0.001. Numbers reﬂect total
numbers of differentially expressed genes within each category.
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Table 1. DAVID functional clustering for upregulated or downreguated genes.
DAVID Functional Clustering for upregulated genes
Enrichment score Description p-value
2.37 Chaperones 4.27E-03
1.56 Nucleotide biosynthesis and transcription 2.75E-02
1.49 Stress response 3.24E-02
1.20 RNA helicase 6.31E-02
0.95 Ligase 1.12E-01
0.86 Mitochondrial import 1.39E-01
0.86 Nucleotide binding 1.39E-01
0.85 Nucleotide metabolism 1.42E-01
0.76 Mitochondrial membrane 1.75E-01
0.50 tRNA metabolism 3.17E-01
0.46 rRNA metabolism 3.50E-01
0.43 Ion binding 3.72E-01
0.38 Translation 4.14E-01
0.32 RNA binding 4.84E-01
0.30 WD40 proteins 4.97E-01
0.29 Heat shock 5.13E-01
0.28 Protein complex assembly 5.28E-01
0.10 Proteolysis 7.90E-01
DAVID Functional Clustering for downregulated genes
Enrichment score Description p-value
3.20 Cytoskeleton binding 6.31E-04
2.44 Invasion 3.63E-03
1.55 Cytoskeleton organisation 2.82E-02
1.50 Ankyrin repeat proteins 3.16E-02
1.24 CoA metabolism and respiration 5.75E-02
0.73 Metail ion transport 1.86E-01
0.73 Generation of mitochondrial metabolic precursors 1.87E-01
0.70 Transmembrane proteins 2.01E-01
0.66 Calcium binding 2.21E-01
0.54 Ion binding 2.90E-01
0.53 Inorganic cation transmembrane transport 2.97E-01
0.40 Protease 4.00E-01
0.33 Transcriptional regulation 4.69E-01
0.30 Kinases, nucleotide binding 5.05E-01
0.29 Non-membrane bound organelles 5.09E-01
0.28 Macromolecuar transport 5.20E-01
Visualization and Integrated Discovery; (Huang
da et al. 2009a, b), which supports analysis of
Plasmodium gene IDs, to detect enrichment of
particular biological terms among the differentially
expressed genes. The upregulated and down-
regulated gene lists were loaded into the DAVID
interface and subjected to functional annotation
clustering in order to evaluate the representation
of biological terms, using default parameters. The
clustered groups are listed in Table 1; enrichment
scores greater than 1 (bold in Table 1) correspond
to p-value < 0.1.
The functional clustering indicated enrichment
among upregulated genes of transcripts encod-
ing chaperones and stress response proteins,
as well as transcripts encoding proteins involved
in nucleotide biosynthesis/transcription. Among
downregulated genes, there was enrichment of
transcripts encoding cytoskeletal, as well as
invasion-related proteins. Furthermore, there was
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an enrichment of genes encoding proteins involved
in respiration.
Genes Encoding Mitochondrially-targeted
Proteins
Only a small proportion of the differentially
expressed genes encoded proteins targeted to
the mitochondrion. Of the nineteen differen-
tially expressed genes within this category, 14
were upregulated and 5 were downregulated.
Upregulated genes encoded import proteins and
chaperones involved in protein import, while down-
regulated genes encoded proteins involved in
energy metabolism, indicating a functional dis-
tinction between up- and downregulated genes
encoding mitochondrially-targeted proteins. While
the absolute number of differentially expressed
genes encoding mitochondrially-targeted proteins
was small, the gene ontology enrichment analysis
nonetheless indicated that there was enrich-
ment among downregulated genes of tran-
scripts encoding proteins involved in respiration.
Among the ﬁve downregulated transcripts encod-
ing mitochondrially-targeted proteins were genes
encoding two subunits of cytochrome c oxidase
(coxIIb by 0.48 fold and coxVIb by 0.47 fold),
the putative ubiquinone-binding, 14 kDa subunit
of complex III (PF10_0120, 0.56 fold) and citrate
synthase (0.48 fold). However, no other TCA cycle
components were found among the 475 differ-
entially expressed genes. The upregulated genes
included mitochondrial import proteins TIM44 (5.4
fold), GrpE (2.9 fold), Hsp60 (2.7 fold) and TIM23
(3.5 fold). Genes encoding prohibitin andBcs1were
also upregulated. These are believed to act as
chaperones for respiratory proteins. Furthermore,
a 10 kDa chaperonin (PfCpn10) was upregulated
(by 5.4 fold), as were mtHsp90 (3.3 fold) encoded
by PF11_0188 and mtHsp70 (3.1 fold). A sin-
gle cysteine desulphurase (IscS) was upregulated
by 4.5 fold; other components of the iron-sulphur
cluster biogenesis pathway were not differentially
expressed. Three genes encoding mitochondrial
ribosomal proteins were upregulated as well as
PFL1185c, which encodes the enzyme responsible
for insertion of haem into cytochrome c.
Genes for apicoplast-targeted proteins were
not over-represented among the differentially
expressed genes, in spite of the close association
between mitochondrion and apicoplast (Howe and
Purton 2007). Twenty-three differentially expressed
genes (∼ 5%) encoded proteins predicted to be
apicoplast-targeted. Of these, nine were upregu-
lated and 14were downregulated. Five upregulated
genes encoded proteins involved in the expression
and maturation of plastid proteins; two were pro-
teins involved in tRNA synthesis, as well as a fMet
deformylase (1.4 fold increase), an aminopeptidase
(2.0 fold increase) and the apicoplast cochaper-
onin (PfCpn20; 1.9 fold increase). PfCpn20 plays
a role in the maturation of plastid proteins. The
gene encoding PfCpn60 with which it functions was
not found to be upregulated. PFB0270w, an iron-
sulphur assembly protein described as SufE, was
upregulated by 1.9 fold. However, genes for other
components of the Suf pathway were not regulated.
PF13_0157 (which encodes one of two ribose-
phosphate pyrophosphokinases in P. falciparum)
was also upregulated by 2.4 fold. These enzymes
provide 5-phospho-D-ribose 1-pyrophosphate for
purine and pyrimidine biosynthesis.Of the 13 down-
regulated genes encoding apicoplast-targeted
proteins, 8 were of unknown function.
Genes Encoding Stress Response
Proteins and Chaperones
Our analysis of enriched biological terms within
the differentially expressed genes indicated an
enrichment of genes encoding stress response
proteins and chaperones among the upregulated
transcripts. Twenty-one heat shock, chaperone and
stress response protein genes were differentially
expressed. Eighteen of these were upregulated,
of which 17 were upregulated by greater than
1.5 fold and ten by greater than 2 fold. These
included genes for glutaredoxin, glutathione syn-
thase, one thioredoxin-like protein and multiple
proteins annotated as heat shock proteins (or asso-
ciated proteins) or as having DnaJ domains. In
addition two genes encoding proteins involved in
ubiquitin metabolism showed increased expres-
sion. The three downregulated genes in this
category encoded the hsp90 co-chaperone p23 (by
0.57 fold), a putative thioredoxin (0.11 fold) and a
putative ubiquitin transferase (0.077 fold).
We observed a predominant downregulation
of genes encoding transporters. Thirteen genes
encoding transporters showed differential expres-
sion. However, only a single (nucleoside) trans-
porter gene was upregulated while the remain-
der (of varying function) were downregulated;
these included two drug/metabolite transporters,
a Na+/H+ antiporter and Ca2+and two Cu2+ ion
transporters. Gene ontology enrichment analy-
sis did not identify terms within this category as
being signiﬁcantly enriched among the dataset.
However, transporter proteins were among the
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classiﬁcations identiﬁed by DAVID as enriched,
albeit with p-values > 0.1.
Invasion-related Proteins
Twenty-ﬁve genes involved in invasion were down-
regulated, while there were no upregulated genes
in this category. Indeed, the gene ontology enrich-
ment analysis identiﬁed invasion-related terms as
being signiﬁcantly enriched among the downregu-
lated transcripts. Seven genes for rhoptry proteins
were found to be differentially expressed, as were
a number of genes encoding components of
the motor complex required for invasion. These
included GAP50 (0.43 fold), GAP45 (0.25 fold),
myosin A tail interacting protein (0.15 fold) and
multiple membrane skeletal proteins (0.097 – 0.10
fold). Five reticulocyte-binding proteins and three
erythrocyte-binding antigens were also downregu-
lated, all to less than 0.2 fold.
In keeping with the downregulation of invasion-
related genes, nine of the 12 genes encoding
motor proteins or cytoskeletal proteins were down-
regulated. Furthermore, functional terms linked
to the cytoskeleton were identiﬁed as signiﬁ-
cantly enriched among downregulated transcripts.
The downregulated transcripts within this cate-
gory included genes involved in the formation
of/interaction with actin ﬁlaments, as well as genes
for myosin E and myosin D.
Exported and Surface Proteins
Ninety genes encoding surface or exported proteins
belonging to larger gene families exhibited differen-
tial expression and, for the majority of transcripts,
changes were greater than±50%. Thirty-six were
upregulated and 54 were downregulated. Eight
merozoite surface protein genes were differentially
expressed, all of which were downregulated. A
number of single members of large multigene fam-
ilies (e.g. hyp) were also differentially expressed.
Other Features of the Gene Expression
Response to Antimycin A
Genes encoding phosphatases and kinases
were considered as candidate genes with an
involvement in intracellular signalling upon drug
treatment. Ten genes encoding phosphatases
were differentially expressed upon antimycin A
treatment. Four showed increased expression
between 1.8 and 3.3 fold (comprising two genes
for protein phosphatases, an exopolyphosphatase
and diadenosine tetraphosphatase). The 6
downregulated phosphatase genes encoded
protein phosphatases and an inorganic pyrophos-
phatase.
Sixteen kinase genes showed altered expres-
sion upon antimycin A treatment. Of the six
upregulated kinase genes, four encoded FIKK
kinases (MAL7P1.144, PF10_0380, MAL7P1.175
and PFL0040c). Genes encoding protein kinase
6 (MAL13P1.185) and an adenylate kinase
(PFD0755c) also exhibited increased expres-
sion. Downregulated kinase genes included three
for serine/threonine protein kinases, three for
calcium-dependent protein kinases, cGMP- and
cAMP-dependent protein kinases as well as a gene
for an uncharacterised protein kinase (encoded by
PF13_0166).
Sixty-four of the genes differentially expressed
upon antimycin A treatment were involved in tran-
scription, translation or nucleotide binding. Of
these, 50 were upregulated i.e. almost 25% of all
upregulated genes. The genes within this category
included transcripts for ten ribosomal proteins or
proteins involved in ribosome biogenesis, six sub-
units of RNA polymerases I, II and III, two ApiAP2
proteins (PF10_0075 by 1.6 fold, and PFL1075w by
1.6 fold) and eight RNA helicases. Fourteen genes
encoding proteins involved in transcription, trans-
lation or nucleotide binding were downregulated.
Among these were four genes encoding proteins
involved in the regulation of transcription; PfSir2A
encoded by PF13_0152 was downregulated 0.20
fold, ADA2 transcriptional activator was downregu-
lated 0.73 fold and two ApiAP2 proteins encoded
by PFF0200c (0.16 fold) and PF11_0091 (0.49
fold). PFF0200c is known to be involved in telom-
eric maintenance (Flueck et al. 2010). Three genes
encoding zinc ﬁnger proteins were also down-
regulated. Furthermore, functional terms linked
to transcription and nucleotide biosynthesis were
identiﬁed as signiﬁcantly enriched among upregu-
lated transcripts by the gene ontology enrichment
analysis. Additional terms such as translation,
tRNA and rRNAmetabolism, were also identiﬁed by
DAVID as showing some enrichment among upreg-
ulated genes, albeit with p-values higher than 0.1.
Seventy-four genes were deﬁned as ‘other-
metabolism’ as they did not ﬁt into any of
the alternative categories. Thirty-six genes were
upregulated including two encoding proteins
involved in pyridoxal 5-phosphate biosynthesis.
Genes encoding proteins involved in pyrimidine
metabolism were also upregulated, for example
cytidine triphosphate synthetase (5.0 fold), cyti-
dine/deoxycytidylate deaminase (4.0 fold), orotate
phosphoribosyltransferase (3.4 fold) and aspartate
carbamoyltransferase (2.4 fold). Ribose-phosphate
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pyrophosphokinase (which contributes to pyrimi-
dine and purine biosynthesis but is predicted to be
apicoplast targeted) was also upregulated by 2.2
fold.
Thirty-eight genes encoding proteins involved
in additional metabolic pathways were downregu-
lated. The proteins encoded by these geneswere of
varying function but included PfSUB1 and PfSUB2
subtilisin-like proteases and two serine repeat anti-
gens. PfSUB1 is involved in the cleavage of SERAs
prior to egress (Yeoh et al. 2007) and of MSP com-
plexes prior to invasion (Koussis et al. 2009).
Discussion
We have investigated the transcript-level effects
of treatment with the mtETC inhibitor antimycin
A on gene expression in P. falciparum. Twenty-
four hours of treatment with an LD50 concentration
of the drug led to the differential expression of a
large number of genes and these were categorised
into functional groups. Similar proportions of genes
exhibited up- and downregulation. However, the
distribution of genes among functional categories
differed between the up- and downregulated genes.
Gene ontology enrichment analysis using DAVID
indicated that there was enrichment among upreg-
ulated transcripts for genes involved in the stress
response and nucleotide biosynthesis, while down-
regulated transcripts were enriched for genes
involved in invasion and the cytoskeleton.
General Responses to Antimycin A
In general, there was a broad perturbation of
gene expression. Differentially expressed genes
belonged to a range of metabolic pathways. A
large proportion of regulated genes belonged to
large gene families encoding exported proteins and
surface antigens. The bulk regulation of genes
belonging to large, co-expressed, multi-membered
gene families has also been a feature of transcrip-
tional responses of Plasmodium to a number of
other stimuli (Clark et al. 2008; Fang et al. 2004)
and is likely to represent a general rather than drug-
speciﬁc response. We observed such a response
in Plasmodium upon treatment of parasites with the
apicoplast inhibitor thiostrepton (Tarr et al. 2011).
Although the cause of this broadly observed phe-
nomenon is unclear, given the co-expression of
many functionally related genes during the Plas-
modium lifecycle, a possible contribution to the
differential expression of such genes comes from
altered lifecycle progression in drug-treated or
stressed parasites (Clark et al. 2008; Tarr et al.
2011). It is probable that this phenomenon con-
tributes to the observed changes in expression
of invasion-related genes and members of gene
families in response to antimycin A. Similarly, we
observed that while few genes encoding proteins
involved in signalling processes were differentially
expressed upon antimycin A treatment, increased
expression of four genes coding for FIKK fam-
ily kinases occurred i.e. 20% of this family. FIKK
kinase genes are subtelomeric and their differential
expression is in line with the differential expression
of other multi-membered gene families.
Relatively few genes involved in stress response
were differentially expressed in response to
antimycin A treatment. This might suggest that the
parasite responds to mtETC inhibition with limited
upregulation (on a transcriptional level) of the cel-
lular stress response. However, our data showed
that stress response transcripts were almost exclu-
sively upregulated upon antimycin A treatment.
Furthermore, our functional enrichment analysis
also indicated that genes within this category were
enriched among upregulated transcripts. Indeed,
it would not be unexpected that after 24 hours
of treatment, the effects of antimycin A would
be strongly felt beyond the mtETC Interestingly,
the predominant downregulation of genes encod-
ing transporters suggested that the parasite did
not actively respond (on a transcriptional level) to
remove the drug from the cell.
Drug-speciﬁc Responses to Antimycin A
On the basis of the essential function of
the Plasmodium mtETC, we hypothesised that
P. falciparum may exhibit a gene expression
response to antimycin A geared towards over-
coming mitochondrial dysfunction, such as has
been seen in yeast. Nineteen of the genes dif-
ferentially expressed in response to antimycin A
encoded proteins predicted to be targeted to the
mitochondrion. The gene ontology enrichment
analysis suggested an enrichment of proteins
involved in respiration among the downregulated
transcripts. Furthermore, a number of genes
encoding mitochondrial chaperones were upreg-
ulated which may be indicative of a stress
response directed at protecting mitochondrial
proteins. Other upregulated genes encoding
mitochondrially-targeted proteins were predomi-
nantly involved in protein import and folding. This
functional distinction between up regulated and
downregulated genes for mitochondrially-targeted
proteins is of great interest given the target of
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antimycin A within the mitochondrion. Downreg-
ulated transcripts encoded proteins involved in
electron transport and respiration, such as sub-
units of cytochrome c oxidase and complex III.
These observations are in keeping with a some-
what typical retrograde signalling pathway. mtETC
components are often targets of retrograde sig-
nalling in response to mitochondrial dysfunction
(Scarpulla 2002). Additional mining of our dataset
revealed downregulation of transcripts for subunits
B, C and D of succinate dehydrogenase (known to
be regulated on a transcriptional level by ‘Nuclear
Respiratory Factors’ in other organisms (Scarpulla
2002)) upon antimycin A treatment in P. falci-
parum, albeit with p-values greater than 0.001. The
gene encoding mtCpn10 (also known to be tran-
scriptionally regulated in mammalian systems) was
upregulated during the response to antimycin A of
P. falciparum, and in addition, two genes for inner
mitochondrial membrane translocase components
were also upregulated. In mice, the gene encod-
ing mtCpn10 contains recognition sites for Nuclear
Respiratory Factor 1 (NRF-1) which regulates the
expression of many nuclear encoded, mitochon-
drial genes involved in respiration (Scarpulla 2002).
The gene encoding cytochrome c exhibited
upregulation by 2.2 fold (p = 0.0022). In other sys-
tems, the gene encoding cytochrome c is subject
to regulation by NRF-1, as well as the protein
being regulated post-translationally by phosphory-
lation (Hüttemann et al. 2007). Although there is no
clear NRF-1 homologue in Plasmodium, the tyro-
sine residues involved in regulation of the protein
in other organisms are conserved in the Plasmod-
ium cytochrome c (data not shown). This, together
with the upregulation of transcript levels in response
to antimycin A, might suggest that this protein is
important in the parasite’s response to the drug,
or, perhaps more generally, to mtETC dysfunction.
For example, upregulation of the gene might allow
increased removal of electrons from complex III
under conditions of partial inhibition.
Given the close association of the apicoplast and
mitochondrion, and in view of the possibility that the
mitochondrion may depend on the plastid for trans-
lational precursors (Howe and Purton 2007), it was
interesting to observe that only twenty-three differ-
entially expressed genes (∼ 5%) encoded proteins
predicted to be apicoplast-targeted.
The data presented here did not imply a
strong response from genes involved in intra-
cellular signalling, nor did this study address
phosphorylation or allosteric regulation of mtETC
components. However, were the observed tran-
scriptional responses of genes encoding mtETC
subunits reﬂected in the proteome of the mito-
chondrion, a protective response against antimycin
A treatment could be envisaged; the downregula-
tion of mtETC components upstream of complex
III and upregulation of cytochrome c could act to
reduce the production of (for example) superoxide.
This is produced by the reaction of oxygen with
semiquinone at the Qo site of complex III upon inhi-
bition by antimycin A at the Qi site (Murphy 2009).
Nucleotide Metabolism
Our gene ontology enrichment analysis revealed
an enrichment of genes involved in nucleotide
biosynthesis and transcription among upregu-
lated transcripts. In particular, we observed the
upregulation of four genes involved in pyrimi-
dine metabolism. Plasmodium sp. must synthesise
pyrimidines de novo (Gutteridge et al. 1979). There-
fore, the gene expression responses observed here
could indicate an attempt to increase general ﬂux
through the pyrimidine biosynthesis pathway in
order to overcome inhibition of the pathway due
to antimycin A treatment. Pyrimidine biosynthesis
has already been suggested to be dependent on a
functional mtETC (Painter et al. 2007). However, lit-
tle is known about the ﬁne transcriptional regulation
of pyrimidine biosynthesis pathway components in
Plasmodium.
In addition to the signiﬁcant increases in expres-
sion of aspartate carbamoyl transferase and orotate
phosphoribosyl transferase, transcripts for car-
bamoyl phosphate synthetase and dihydroorotase
were also upregulated, albeit less signiﬁcantly
(2.13 fold, p = 0.0018 and 2.51 fold, p = 0.0013,
respectively). These observations perhaps sug-
gest co-regulation of these key genes in an
attempt to increase ﬂux through the inhibited pyrim-
idine biosythesis pathway (in this instance, due
to antimycin A treatment). The strong 3.4 fold
upregulation of the gene encoding orotate phos-
phoribosyl transferase was noteworthy given its
observed upregulation in the presence of uridine
in Medicago truncatula (Brady et al. 2010). The
transcript-level regulation of these genes is in keep-
ing with their regulation in other organisms. It
should be noted that pyrimidine biosynthesis path-
way enzymes are also regulated directly, and this
study did not address the enzyme-level regulation
of the pyrimidine biosynthesis pathway.
The effects of the expression of these genes
require analysis at the protein level in order to
characterise further this response. However, the
observed changes in expression of genes encod-
ing components of the pathway are in keeping with
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those seen in other organisms, giving further weight
to the notion that pyrimidine biosynthesis is vital to
P. falciparum.
The downregulation of genes involved in inva-
sion also indicated an inﬂuence of expression
timing on changes in expression in response to
antimycin A, supporting a lifecycle or gene expres-
sion proﬁle delay in antimycin A-treated parasites
relative to controls. A lifecycle-dependent change
in expression in response to antimycin A also
goes some way to explaining the bulk regulation
of co-expressed members of larger gene families.
Slowing of lifecycle progression could indicate a
general stress response due to perturbation of
essential metabolism, or reﬂect an active delay in
the cell cycle as the parasite ‘waits’ for (in this
case) the drug pressure to be removed. Indeed,
this would be in keeping with the effects of the
antimalarial drug atovaquone on ring stage par-
asites (Painter et al. 2010). These observations
may well be similar to the arrest/delay of ring stage
parasites during 24 hours of atovaquone treatment
(Painter et al. 2010). The gene expression data
did not provide much indication of factors respon-
sible for these effects. However, the majority of
regulators involved in lifecycle progression of P.
falciparum are just beginning to be understood
(Koyama et al. 2009). Candidates highlighted in
the microarray data presented here could include
the genes encoding ApiAP2 proteins PF10_0075,
PFL1075w and PF11_0091. While these require
comprehensive characterisation, there is indication
that one of the ApiAP2 domains of PF10_0075 has
target sequence binding sites upstream of a num-
ber of developmental and invasion-related genes
(Campbell et al. 2010). This raises the possibility
that this protein may link the parasite’s response to
antimycin A with lifecycle progression.
The results presented here are in line with a
‘multi-level’ gene expression response to drug
treatment. While downregulation of invasion-
related genes is in keeping with an inﬂuence of
delayed lifecycle progression on gene expression,
the upregulation of enzymes of pyrimidine biosyn-
thesis may be suggestive of an attempt to maintain
the essential production of pyrimidines, which may
link to the dependence of pyrimidine biosynthesis
on the mtETC. Additionally, downregulation of
genes encoding mtETC components combined
with the increased expression of mitochondrial
chaperones suggests a protective response
against an inhibited mtETC, indicating regulation
of nuclear genes encoding mitochondrion-targeted
proteins upon disruption of mitochondrial function.
The results presented here are suggestive of novel
signalling pathways within Plasmodium and further
investigation of the mechanisms underlying these
responses will be crucial for understanding how
the parasite counters drug challenges.
Methods
P. falciparum culture: Blood stage P. falciparum 3D7 was
maintained in continuous culture in vitro at 37 ◦C using the
candle-jar method (Trager and Jensen 1976). Cultures were
maintained in citrated human blood at 2% hematocrit with com-
plete culture media (RPMI 1640+L-Glutamine (Gibco) with 5%
w/v AlbuMAX I (Invitrogen), 50gml-1 hypoxanthine, 25mM
HEPES (Gibco) and 25gml-1 gentamycin (Sigma), pH7.6).
Parasitaemia was assessed by thin blood smears stained with
Giemsa (Sigma). Percentage infection of red blood cells was
determined by cell counts under an oil immersion light micro-
scope. Synchronous parasites were obtained by the Stockholm
sorbitol method on two consecutive life cycles (Haeggström and
Schlichtherle 2004). All work involving human bloodwas carried
out in accordance with the Human Tissue Act (2004).
Growth inhibition analysis: The effect on growth of ranges
of drug concentrations on P. falciparum cultures was assessed
over one complete lifecycle. Experiments were conducted in
triplicate 150l cultures in 96 well plates. Brieﬂy, synchronous,
ring stage parasites at 2% parasitaemia were treated 1:2000
with drug stocks at 2000 x concentration. Three to four drug
concentrationswere studied for each of four independent exper-
iments. Cultures were incubated in the presence of the drug
(or solvent in the case of controls) for 48 hours. Ring stage
parasites present after 48 hours were deemed to have com-
pleted one lifecycle. Percent infection with ring stage parasites
was ascertained by cell count as described above. Cell survival
was expressed as a fraction of percent rings in treated cul-
tures per percent rings in control cultures. Standard deviation
was expressed as the combined standard deviation of percent
parasitaemia in treated and untreated cultures.
Gene expression analysis: Triplicate 15ml cultures con-
taining synchronous, ring stage parasites at 5% parasitaemia
were treated with 600 nM antimycin A in DMSO (or 1/2000 vol.
DMSO for controls) for 24 hours. RNA was harvested using Tri-
zol (Invitrogen) as described (Kyes 2004). RNA concentration
and purity were determined using a NanoDrop (Thermo) and
RNA integrity was tested using an Agilent Bioanalyzer (Cam-
bridge Genomic Services, Department of Pathology).
Labelled RNA was hybridised to Plasmodium/Anopheles
Genechip microarrays (Affymetrix). Microarray cRNA syn-
thesis, hybridisation and plate-reading were conducted by
Geneservice (Nottingham, UK). Raw CEL ﬁles were imported
into Bioconductor (Gentleman et al. 2004) for data analysis.
Microarrays were analysed for RNA degradation prior to nor-
malisation. Non-Plasmodium probesets were removed using
the altcdfenvs package (Gautier et al. 2004) and microar-
ray data were normalised using GCRMA (Wu et al. 2004).
The microarray data were deposited as a Gene Expres-
sion Omnibus accession (http://www.ncbi.nlm.nih.gov/geo/;
GSE28625). Differential gene expression was analysed using
Linear Models for Microarray Analysis (LIMMA) (Smyth 2004);
normalised gene expression values for antimycin A-treated par-
asites were contrasted against untreated (DMSO) controls.
Gene annotations for the differentially expressed transcripts
were downloaded from PlasmoDB (http://www.plasmodb.org).
However, due to the gene-to-gene variation in annotation within
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PlasmoDB, categorisation of the differentially expressed tran-
scripts was conducted manually, based the available gene
ontology information.
Differential expression of twelve genes (PF14 0641,
PF13 0040, PF14 0133, PFL1550w, PFI0735c, PF10 0334,
MAL8P1.70, PF13 0058, MAL7P1.176, PF14 0373,
MAL13P1.255 and PFF0160c) from the microarray analysis
was validated by quantitative RT-PCR. Seryl-tRNA synthetase
(PF07 0073) was used as an internal house-keeping control
gene (Niang et al. 2009). Brieﬂy, contaminating DNA was
removed from extracted RNA using DNAfree (Ambion) as per
manufacturer’s instructions and cDNA was generated using
Superscript II (Invitrogen) using 300 ng RNA randomly reverse
primed with 100 ng random AT hexamer per 40l reaction, as
per manufacturer’s instructions (with the exception that reverse
transcription was carried out at 37 ◦C). cDNA was diluted 1 in 5
for qRT-PCR analysis. qRT-PCR primers were designed using
Primer3 (http://frodo.wi.mit.edu/primer3; see Supplementary
Table 1 for primer sequences). Ampliﬁcation efﬁciencies were
conﬁrmed prior to gene expression analysis. 5l of template
cDNA was used per 25l qRT-PCR reaction, with 300 nM
(ﬁnal concentration) each forward and reverse primers in Sybr
Green PCR premix (Applied Biosystems). qRT-PCR reactions
were run in an ABIPrism 7300 real-time thermal cycler as
appropriate for the Sybr Green PCR premix. Thermal cycling
was followed by melt curve analysis. Baseline and threshold
cycles were analysed using default settings. Relative fold
changes in gene expression were calculated by the 2-CT
relative quantiﬁcation method (Livak and Schmittgen 2001).
Reactions were conducted in technical quadruplicate and the
raw CT values of the replicates were subjected to the Grubb’s
test for outliers. The values were averaged and used in the
subsequent fold-change calculation. The fold change values for
three to four independent triplicate experiments were pooled for
each gene and subjected to a non-parametric Mann-Whitney U
test in StatView (version 4.51, Abacus Concepts). Correlation
of qRT-PCR data with microarray-derived data was tested
using the Spearman’s Rank Correlation in StatView (Abacus
Concepts, version 4.5).
Gene ontology enrichment analysis: Enrichment for bio-
logical terms in the lists of differentially expressed genes was
analysed using the functional annotation clustering program of
the Database for Annotation, Visualization and Integrated Dis-
covery (Huang da et al. 2009a, b). The analysis was performed
by inputting PlasmoDB gene identiﬁers for genes identiﬁed as
being up- or downregulated by themicroarray analysis, followed
by comparison to all P. falciparum genes in order to assess
enrichment. Analysis was performed under default conditions
such that gene annotations for Clusters of Orthologous Groups
ontology, Uniprot sequence features, biological process, cel-
lular component and molecular function Gene Ontology terms,
Kyoto Encyclopedia of Genes andGenomes pathways, Interpro
domains, Protein Information Resource superfamily annota-
tions and SMART domains were considered. Cluster names
were derived from the biological terms found within each clus-
ter. P-values outputted by DAVID were the geometric mean
of the individual p-values (calculated by a Fisher’s exact test)
within each clustered group. Enrichment scores presented are
the negative log of the p-values for each cluster.
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